Periscope Pediatric Migraine Study
This clinical trial aims to evaluate an investigational product for the treatment of migraines in children and adolescents aged 6 to 17. The goal is to assess the product's effectiveness and safety in reducing the frequency and severity of migraine episodes in the pediatric population.
ELIGIBILITY CRITERIA
We are seeking participants who meet the following criteria:
- Children and adolescents aged 6 to 17.
- Diagnosed with migraines.
Study Details
Participants in this clinical trial will receive the investigational product designed to treat migraines. The study will closely monitor the product’s effectiveness and safety through regular assessments conducted by a team of medical professionals.
During the trial, participants will attend scheduled visits for check-ups and to track changes in migraine frequency and severity. The study aims to determine whether the investigational product can provide significant relief and improve the quality of life for children and adolescents suffering from migraines.
Interventions:
Administration of the investigational product aimed at treating migraines in the pediatric population.
Do you meet the criteria and want to join the study?
If your child meets the criteria and you are interested in contributing to this important research, they may qualify for this study. For more information or to discuss eligibility, please contact the Haltha team at Haltha Connect.
Take part in live studyUnlock Exclusive Content by Subscribing to Our Updates
Stay informed about the latest advancements, breakthroughs, and trends in medical research